Skip to main content
Top
Published in: BMC Gastroenterology 1/2009

Open Access 01-12-2009 | Research article

Gastroparesis is associated with oxytocin deficiency, oesophageal dysmotility with hyperCCKemia, and autonomic neuropathy with hypergastrinemia

Authors: Julia Borg, Olle Melander, Linda Johansson, Kerstin Uvnäs-Moberg, Jens F Rehfeld, Bodil Ohlsson

Published in: BMC Gastroenterology | Issue 1/2009

Login to get access

Abstract

Background

Gastrointestinal (GI) dysmotility and autonomic neuropathy are common problems among diabetics with largely unknown aetiology. Many peptides are involved in the autonomic nervous system regulating the GI tract. The aim of this study was to examine if concentrations of oxytocin, cholecystokinin (CCK), gastrin and vasopressin in plasma differ between diabetics with normal function and dysfunction in GI motility.

Methods

Nineteen patients with symptoms from the GI tract who had been examined with gastric emptying scintigraphy, oesophageal manometry, and deep-breathing test were included. They further received a fat-rich meal, after which blood samples were collected and plasma frozen until analysed for hormonal concentrations.

Results

There was an increase in postprandial oxytocin plasma concentration in the group with normal gastric emptying (p = 0.015) whereas subjects with delayed gastric emptying had no increased oxytocin secretion (p = 0.114). Both CCK and gastrin levels increased after the meal, with no differences between subjects with normal respective delayed gastric emptying. The concentration of vasopressin did not increase after the meal. In patients with oesophageal dysmotility the basal level of CCK tended to be higher (p = 0.051) and those with autonomic neuropathy had a higher area under the curve (AUC) of gastrin compared to normal subjects (p = 0.007).

Conclusion

Reduced postprandial secretion of oxytocin was found in patients with delayed gastric emptying, CCK secretion was increased in patients with oesophageal dysmotility, and gastrin secretion was increased in patients with autonomic neuropathy. The findings suggest that disturbed peptide secretion may be part of the pathophysiology of digestive complications in diabetics.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wegener M, Borsch G, Schaffstein J, Luerweg C, Lewerkus F: Gastrointestinal transit disorders in patients with insulin treated diabetes mellitus. Dig Dis. 1990, 8: 23-26. 10.1159/000171237.CrossRefPubMed Wegener M, Borsch G, Schaffstein J, Luerweg C, Lewerkus F: Gastrointestinal transit disorders in patients with insulin treated diabetes mellitus. Dig Dis. 1990, 8: 23-26. 10.1159/000171237.CrossRefPubMed
2.
go back to reference Horowitz M, Maddox AF, Wishart JM, Harding PE, Chatterton BE, Shearman DJC: Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med. 1991, 18: 229-234. 10.1007/BF00186645.CrossRefPubMed Horowitz M, Maddox AF, Wishart JM, Harding PE, Chatterton BE, Shearman DJC: Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med. 1991, 18: 229-234. 10.1007/BF00186645.CrossRefPubMed
3.
go back to reference Faraj J, Melander O, Sundkvist G, Olsson R, Thorson O, Ekberg O, Ohlsson B: Oesophageal dysmotility, delayed gastric emptying and gastrointestinal symptoms in patients with diabetes mellitus. Diabet Med. 2007, 24: 1235-1239. 10.1111/j.1464-5491.2007.02236.x.CrossRefPubMed Faraj J, Melander O, Sundkvist G, Olsson R, Thorson O, Ekberg O, Ohlsson B: Oesophageal dysmotility, delayed gastric emptying and gastrointestinal symptoms in patients with diabetes mellitus. Diabet Med. 2007, 24: 1235-1239. 10.1111/j.1464-5491.2007.02236.x.CrossRefPubMed
4.
go back to reference Clark WD, Nowak VT, Diabetic gastroparesis: What to do when gastric emptying is delayed. Postgrad Med. 1994, 95: 195-204.PubMed Clark WD, Nowak VT, Diabetic gastroparesis: What to do when gastric emptying is delayed. Postgrad Med. 1994, 95: 195-204.PubMed
5.
go back to reference Ejskjaer NT, Bradley JL, Buxton-Thomas MS, Edmonds ME, Howard EK, Purewal T, Thomas PK, Watkins PJ: Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med. 1999, 16: 488-495. 10.1046/j.1464-5491.1999.00086.x.CrossRefPubMed Ejskjaer NT, Bradley JL, Buxton-Thomas MS, Edmonds ME, Howard EK, Purewal T, Thomas PK, Watkins PJ: Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med. 1999, 16: 488-495. 10.1046/j.1464-5491.1999.00086.x.CrossRefPubMed
6.
go back to reference Ordog T, Takayama I, Cheung WK, Ward SM, Sanders KM: Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes. 2000, 49: 1731-1739. 10.2337/diabetes.49.10.1731.CrossRefPubMed Ordog T, Takayama I, Cheung WK, Ward SM, Sanders KM: Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes. 2000, 49: 1731-1739. 10.2337/diabetes.49.10.1731.CrossRefPubMed
7.
go back to reference Yoshida MM, Schuffler MD, Sumi SM: There are no morphologic abnormalities of the gastric wall or abdominal vagus in patients with diabetic gastroparesis. Gastroenterology. 1988, 94: 907-914.CrossRefPubMed Yoshida MM, Schuffler MD, Sumi SM: There are no morphologic abnormalities of the gastric wall or abdominal vagus in patients with diabetic gastroparesis. Gastroenterology. 1988, 94: 907-914.CrossRefPubMed
8.
go back to reference Monstein H-J, Grahn N, Truedsson M, Ohlsson B: Oxytocin and oxytocin receptor mRNA expression in the human gastrointestinal tract: A polymerase chain reaction study. Reg Pept. 2004, 119: 39-44. 10.1016/j.regpep.2003.12.017.CrossRef Monstein H-J, Grahn N, Truedsson M, Ohlsson B: Oxytocin and oxytocin receptor mRNA expression in the human gastrointestinal tract: A polymerase chain reaction study. Reg Pept. 2004, 119: 39-44. 10.1016/j.regpep.2003.12.017.CrossRef
9.
go back to reference Ohlsson B, Truedsson M, Djerf P, Sundler F: Oxytocin is present throughout the human gastrointestinal tract. Reg Pept. 2006, 135: 7-11. 10.1016/j.regpep.2006.03.008.CrossRef Ohlsson B, Truedsson M, Djerf P, Sundler F: Oxytocin is present throughout the human gastrointestinal tract. Reg Pept. 2006, 135: 7-11. 10.1016/j.regpep.2006.03.008.CrossRef
10.
go back to reference Ohlsson B, Forsling ML, Rehfeld JF, Sjölund K: Cholecystokinin leads to increased oxytocin secretion in healthy women. Eur J Surg. 2002, 168: 114-118. 10.1080/11024150252884340.CrossRefPubMed Ohlsson B, Forsling ML, Rehfeld JF, Sjölund K: Cholecystokinin leads to increased oxytocin secretion in healthy women. Eur J Surg. 2002, 168: 114-118. 10.1080/11024150252884340.CrossRefPubMed
11.
go back to reference Hashmonai M, Torem S, Argov S, Barzilai A, Schramek A: Prolonged post-vagotomy gastric atony treated by oxytocin. Br J Surg. 1979, 66: 550-551. 10.1002/bjs.1800660809.CrossRefPubMed Hashmonai M, Torem S, Argov S, Barzilai A, Schramek A: Prolonged post-vagotomy gastric atony treated by oxytocin. Br J Surg. 1979, 66: 550-551. 10.1002/bjs.1800660809.CrossRefPubMed
13.
go back to reference Ohlsson B, Björgell O, Ekberg O, Darwiche G: The oxytocin/vasopressin receptor antagonist atosiban delays the gastric emptying of a semisolid meal compared to saline in human. BMC Gastroenterology. 2006, 6: 11-10.1186/1471-230X-6-11.CrossRefPubMedPubMedCentral Ohlsson B, Björgell O, Ekberg O, Darwiche G: The oxytocin/vasopressin receptor antagonist atosiban delays the gastric emptying of a semisolid meal compared to saline in human. BMC Gastroenterology. 2006, 6: 11-10.1186/1471-230X-6-11.CrossRefPubMedPubMedCentral
14.
go back to reference Grider JR: Role of cholecystokinin in the regulation of gastrointestinal motility. J Nutr. 1994, 124: 1334S-1339S.PubMed Grider JR: Role of cholecystokinin in the regulation of gastrointestinal motility. J Nutr. 1994, 124: 1334S-1339S.PubMed
15.
go back to reference Rehfeld JF: The new biology of gastrointestinal hormones. Physiol Rev. 1998, 78 (4): 1087-1108.PubMed Rehfeld JF: The new biology of gastrointestinal hormones. Physiol Rev. 1998, 78 (4): 1087-1108.PubMed
16.
go back to reference Sasaki H, Nagulesparan M, Dubois A, Straus E, Samloff IM, Lawrence WH, Johnson GC, Sievers ML, Unger RH: Hypergastrinemia in obese noninsulin-dependent diabetes: A possible reflection of high prevalence of vagal dysfunction. J Clin Endocrin Metab. 1983, 56 (4): 744-750.CrossRef Sasaki H, Nagulesparan M, Dubois A, Straus E, Samloff IM, Lawrence WH, Johnson GC, Sievers ML, Unger RH: Hypergastrinemia in obese noninsulin-dependent diabetes: A possible reflection of high prevalence of vagal dysfunction. J Clin Endocrin Metab. 1983, 56 (4): 744-750.CrossRef
17.
go back to reference Kanatsuka A, Osegawa M, An T, Suzuki T, Hashimoto N, Makino H: Augmented gastrin responses in diabetic patients with vagal neuropathy. Diabetologia. 1984, 26: 449-452. 10.1007/BF00262219.CrossRefPubMed Kanatsuka A, Osegawa M, An T, Suzuki T, Hashimoto N, Makino H: Augmented gastrin responses in diabetic patients with vagal neuropathy. Diabetologia. 1984, 26: 449-452. 10.1007/BF00262219.CrossRefPubMed
18.
go back to reference Nakamura T, Takebe K, Imamura K-I, Miyazawa T, Ishii M, Kudoh K, Terada A, Machida K, Kikuchi H, Kasai F, Tandoh Y, Arai Y, Yamada N: Decreased gastric secretory functions in diabetic patients with autonomic neuropathy. Tohoku J Exp Med. 1994, 173: 199-208. 10.1620/tjem.173.199.CrossRefPubMed Nakamura T, Takebe K, Imamura K-I, Miyazawa T, Ishii M, Kudoh K, Terada A, Machida K, Kikuchi H, Kasai F, Tandoh Y, Arai Y, Yamada N: Decreased gastric secretory functions in diabetic patients with autonomic neuropathy. Tohoku J Exp Med. 1994, 173: 199-208. 10.1620/tjem.173.199.CrossRefPubMed
19.
go back to reference Glasbrenner B, Dominguez-Munoz E, Riepl RL, Vetsi A, Malfertheiner P: Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy. Dig Dis Sci. 1995, 40: 406-411. 10.1007/BF02065429.CrossRefPubMed Glasbrenner B, Dominguez-Munoz E, Riepl RL, Vetsi A, Malfertheiner P: Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy. Dig Dis Sci. 1995, 40: 406-411. 10.1007/BF02065429.CrossRefPubMed
20.
go back to reference Migdalis I, Thomaides T, Chairopoulos C, Kalogeropoulou C, Charalabides J, Mantzara F: Changes of gastric emptying rate and gastrin levels are early indicators of autonomic neuropathy in type II diabetic patients. Clin Auton Res. 2001, 11: 259-263. 10.1007/BF02298958.CrossRefPubMed Migdalis I, Thomaides T, Chairopoulos C, Kalogeropoulou C, Charalabides J, Mantzara F: Changes of gastric emptying rate and gastrin levels are early indicators of autonomic neuropathy in type II diabetic patients. Clin Auton Res. 2001, 11: 259-263. 10.1007/BF02298958.CrossRefPubMed
21.
go back to reference Frank JW, Saslow SB, Camilleri M, Thomforde GM, Dinneen S, Rizza RA: Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology. 1995, 109: 755-765. 10.1016/0016-5085(95)90382-8.CrossRefPubMed Frank JW, Saslow SB, Camilleri M, Thomforde GM, Dinneen S, Rizza RA: Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology. 1995, 109: 755-765. 10.1016/0016-5085(95)90382-8.CrossRefPubMed
22.
go back to reference Monstein HJ, Truedsson M, Ryberg A, Ohlsson B: The vasopressin receptor mRNA expression in non-tumor tissues of the human gastrointestinal tract. Eur Surg Res. 2007, 40: 34-40. 10.1159/000108655.CrossRefPubMed Monstein HJ, Truedsson M, Ryberg A, Ohlsson B: The vasopressin receptor mRNA expression in non-tumor tissues of the human gastrointestinal tract. Eur Surg Res. 2007, 40: 34-40. 10.1159/000108655.CrossRefPubMed
23.
go back to reference Caras SD, Soykan I, Beverly V, Lin Z, McCallum RW: The effect of intravenous vasopressin on gastric myoelectrical activity in human subjects. Neurogastroenterol Motil. 1979, 9: 151-156. 10.1046/j.1365-2982.1997.d01-37.x.CrossRef Caras SD, Soykan I, Beverly V, Lin Z, McCallum RW: The effect of intravenous vasopressin on gastric myoelectrical activity in human subjects. Neurogastroenterol Motil. 1979, 9: 151-156. 10.1046/j.1365-2982.1997.d01-37.x.CrossRef
24.
go back to reference Kim MS, Chey WD, Owyang C, Hasler WL: Role of plasma vasopressin as a mediator of nausea and gastric slow wave dysrythmias in motion sickness. Am J Physiol. 1997, 272: G853-G862.PubMed Kim MS, Chey WD, Owyang C, Hasler WL: Role of plasma vasopressin as a mediator of nausea and gastric slow wave dysrythmias in motion sickness. Am J Physiol. 1997, 272: G853-G862.PubMed
25.
go back to reference Ohlsson B, Melander O, Thorson O, Olsson R, Ekberg O, Sundkvist G: Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasis. Diabetologia. 2006, 49: 2010-2014. 10.1007/s00125-006-0354-9.CrossRefPubMed Ohlsson B, Melander O, Thorson O, Olsson R, Ekberg O, Sundkvist G: Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasis. Diabetologia. 2006, 49: 2010-2014. 10.1007/s00125-006-0354-9.CrossRefPubMed
26.
go back to reference Collins PJ, Horowitz M, Cook DJ, Harding PE, Shearman DJ: Gastric emptying in normal subjects: a reproducible technique using a single scintillation camera and computer system. Gut. 1983, 24: 1117-1125. 10.1136/gut.24.12.1117.CrossRefPubMedPubMedCentral Collins PJ, Horowitz M, Cook DJ, Harding PE, Shearman DJ: Gastric emptying in normal subjects: a reproducible technique using a single scintillation camera and computer system. Gut. 1983, 24: 1117-1125. 10.1136/gut.24.12.1117.CrossRefPubMedPubMedCentral
27.
go back to reference Hanson M, Lilja B: Gastric emptying in smokers. Scand J Gastroenterol. 1987, 22: 1102-1104. 10.3109/00365528708991965.CrossRefPubMed Hanson M, Lilja B: Gastric emptying in smokers. Scand J Gastroenterol. 1987, 22: 1102-1104. 10.3109/00365528708991965.CrossRefPubMed
30.
go back to reference Forsen A, Kangro M, Sterner G, Norrgren K, Thorsson O, Wollmer P, Sundkvist G: A 14-year prospective study of autonomic nerve function in type 1 diabetic patients: association with neuropathy. Diabet Med. 2004, 21: 852-858. 10.1111/j.1464-5491.2004.01255.x.CrossRefPubMed Forsen A, Kangro M, Sterner G, Norrgren K, Thorsson O, Wollmer P, Sundkvist G: A 14-year prospective study of autonomic nerve function in type 1 diabetic patients: association with neuropathy. Diabet Med. 2004, 21: 852-858. 10.1111/j.1464-5491.2004.01255.x.CrossRefPubMed
31.
go back to reference Rehfeld JF: Accurate measurement of cholecystokinin in plasma. Clin Chem. 1998, 44: 991-1001.PubMed Rehfeld JF: Accurate measurement of cholecystokinin in plasma. Clin Chem. 1998, 44: 991-1001.PubMed
32.
go back to reference Rehfeld JF, Stadil F, Rubin B: Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest. 1972, 30: 221-232. 10.3109/00365517209081114.CrossRefPubMed Rehfeld JF, Stadil F, Rubin B: Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest. 1972, 30: 221-232. 10.3109/00365517209081114.CrossRefPubMed
33.
go back to reference Stadil F, Rehfeld JF: Preparation of 125 I-labelled human gastrin for radioimmunoanalysis. Scand J Clin Lab Invest. 1972, 30: 361-369. 10.3109/00365517209080271.CrossRefPubMed Stadil F, Rehfeld JF: Preparation of 125 I-labelled human gastrin for radioimmunoanalysis. Scand J Clin Lab Invest. 1972, 30: 361-369. 10.3109/00365517209080271.CrossRefPubMed
34.
go back to reference Rooke P, Baylis PH: A new sensitive radioimmunoassay for plasma arginine vasopressin. J Immunoassay. 1982, 3: 115-131. 10.1080/15321818208056990.CrossRefPubMed Rooke P, Baylis PH: A new sensitive radioimmunoassay for plasma arginine vasopressin. J Immunoassay. 1982, 3: 115-131. 10.1080/15321818208056990.CrossRefPubMed
35.
go back to reference Gutkowska J, Jankowski M, Lambert C, Mukaddam-Daher S, Zingg HH, McCann SM: Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci. 1979, 94: 11704-11709. 10.1073/pnas.94.21.11704.CrossRef Gutkowska J, Jankowski M, Lambert C, Mukaddam-Daher S, Zingg HH, McCann SM: Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci. 1979, 94: 11704-11709. 10.1073/pnas.94.21.11704.CrossRef
36.
go back to reference Thibonnier M, Conarty DM, Preston JA, Plesnicher CL, Dweik RA, Erzurum SC: Human vascular endothelial cells express oxytocin receptors. Endocrinology. 1999, 140: 1301-1309. 10.1210/en.140.3.1301.PubMed Thibonnier M, Conarty DM, Preston JA, Plesnicher CL, Dweik RA, Erzurum SC: Human vascular endothelial cells express oxytocin receptors. Endocrinology. 1999, 140: 1301-1309. 10.1210/en.140.3.1301.PubMed
37.
go back to reference Ohlsson B, Ringström G, Abrahamsson H, Simrén M, Björnsson ES: Oxytocin stimulates colonic motor activity in healthy women. Neurogastroenterol Mot. 2004, 16: 233-240. 10.1111/j.1365-2982.2004.00507.x.CrossRef Ohlsson B, Ringström G, Abrahamsson H, Simrén M, Björnsson ES: Oxytocin stimulates colonic motor activity in healthy women. Neurogastroenterol Mot. 2004, 16: 233-240. 10.1111/j.1365-2982.2004.00507.x.CrossRef
38.
go back to reference Gimpl G, Fahrenholz F: The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001, 81: 629-683.PubMed Gimpl G, Fahrenholz F: The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001, 81: 629-683.PubMed
39.
go back to reference Verbalis JG, McCann MJ, McHale CM, Stricker EM: Oxytocin secretion in response to cholecystokinin and food: Differentiation of nausea from satiety. Science. 1986, 232: 1417-1419. 10.1126/science.3715453.CrossRefPubMed Verbalis JG, McCann MJ, McHale CM, Stricker EM: Oxytocin secretion in response to cholecystokinin and food: Differentiation of nausea from satiety. Science. 1986, 232: 1417-1419. 10.1126/science.3715453.CrossRefPubMed
40.
go back to reference Ohlsson B, Rehfeld JF, Forsling ML: Oxytocin and cholecystokinin secretion in women with colectomy. BMC Gastroenterology. 2004, 4: 25-10.1186/1471-230X-4-25.CrossRefPubMedPubMedCentral Ohlsson B, Rehfeld JF, Forsling ML: Oxytocin and cholecystokinin secretion in women with colectomy. BMC Gastroenterology. 2004, 4: 25-10.1186/1471-230X-4-25.CrossRefPubMedPubMedCentral
41.
go back to reference Sjölund K, Bartosik I, Lindberg G, Scheja A, Wildt M, Åkesson A: Small intestinal 4 manometry in patients with systemic sclerosis. Eur J Gastroenterol Hepatol. 2005, 17: 1205-1212. 10.1097/00042737-200511000-00009.CrossRefPubMed Sjölund K, Bartosik I, Lindberg G, Scheja A, Wildt M, Åkesson A: Small intestinal 4 manometry in patients with systemic sclerosis. Eur J Gastroenterol Hepatol. 2005, 17: 1205-1212. 10.1097/00042737-200511000-00009.CrossRefPubMed
42.
go back to reference Bucceri AM, Calogero AE, Brogna A: Gallbladder and gastric emptying: relationship to cholecystokinemia in diabetics. Eur J Int Med. 2002, 13: 123-128. 10.1016/S0953-6205(02)00003-1.CrossRef Bucceri AM, Calogero AE, Brogna A: Gallbladder and gastric emptying: relationship to cholecystokinemia in diabetics. Eur J Int Med. 2002, 13: 123-128. 10.1016/S0953-6205(02)00003-1.CrossRef
43.
go back to reference Pinto HC, Portela-Gomes GM, Grimelius L, Kohnert KD, de Sousa JC, Albuquerque MA: The distribution of endocrine cell types of the gastrointestinal mucosa in genetically diabetic (db/db) mice. Gastroenterology. 1995, 108: 967-974. 10.1016/0016-5085(95)90191-4.CrossRefPubMed Pinto HC, Portela-Gomes GM, Grimelius L, Kohnert KD, de Sousa JC, Albuquerque MA: The distribution of endocrine cell types of the gastrointestinal mucosa in genetically diabetic (db/db) mice. Gastroenterology. 1995, 108: 967-974. 10.1016/0016-5085(95)90191-4.CrossRefPubMed
44.
go back to reference Chen D, Uribe A, Håkanson R, Sundler F: Somatostatin cells in the oxyntic mucosa of hypo- or hypergastrinemic rats. Scand J Gastroenterol. 1992, 27: 479-482. 10.3109/00365529209000108.CrossRefPubMed Chen D, Uribe A, Håkanson R, Sundler F: Somatostatin cells in the oxyntic mucosa of hypo- or hypergastrinemic rats. Scand J Gastroenterol. 1992, 27: 479-482. 10.3109/00365529209000108.CrossRefPubMed
45.
go back to reference Gultekin F, Gurbilek M, Vatansev H, Yasar S, Akoz M, Ozturk M: Effect of oral glucose loading on serum gastrin level in pregnant and non-pregnant women. Croat Med J. 2001, 42: 151-155.PubMed Gultekin F, Gurbilek M, Vatansev H, Yasar S, Akoz M, Ozturk M: Effect of oral glucose loading on serum gastrin level in pregnant and non-pregnant women. Croat Med J. 2001, 42: 151-155.PubMed
Metadata
Title
Gastroparesis is associated with oxytocin deficiency, oesophageal dysmotility with hyperCCKemia, and autonomic neuropathy with hypergastrinemia
Authors
Julia Borg
Olle Melander
Linda Johansson
Kerstin Uvnäs-Moberg
Jens F Rehfeld
Bodil Ohlsson
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2009
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-9-17

Other articles of this Issue 1/2009

BMC Gastroenterology 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.